InspireMD (NSPR) Share-based Compensation Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52.53% |
| Sep 30, 2025 | 32.09% |
| Jun 30, 2025 | 85.49% |
| Mar 31, 2025 | 108.66% |
| Dec 31, 2024 | 125.76% |
| Sep 30, 2024 | 53.34% |
| Jun 30, 2024 | 44.04% |
| Mar 31, 2024 | 107.54% |
| Dec 31, 2023 | 207.48% |
| Sep 30, 2023 | 281.96% |
| Jun 30, 2023 | 101.50% |
| Mar 31, 2023 | 50.05% |
| Dec 31, 2022 | 43.73% |
| Sep 30, 2022 | 38.70% |
| Jun 30, 2022 | 24.98% |
| Mar 31, 2022 | 19.95% |
| Dec 31, 2021 | 31.86% |
| Sep 30, 2021 | 8.41% |
| Jun 30, 2021 | 8.99% |
| Mar 31, 2021 | -3.40% |
| Dec 31, 2020 | -7.41% |
| Jun 30, 2020 | -44.52% |
| Mar 31, 2020 | -41.75% |
| Mar 31, 2019 | -41.81% |
| Sep 30, 2018 | -14.90% |
| Jun 30, 2018 | -58.97% |
| Mar 31, 2018 | -50.66% |
| Dec 31, 2017 | -34.56% |
| Sep 30, 2017 | -32.76% |
| Mar 31, 2017 | -26.03% |
| Dec 31, 2016 | -56.00% |
| Sep 30, 2016 | -35.64% |
| Jun 30, 2016 | -15.96% |
| Mar 31, 2016 | -0.05% |
| Dec 31, 2015 | 13.60% |